Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
---|---|---|---|---|---|
Compugen LtdCGEN | +177.42% | $0.93 | $2.58 | 2023-05-24 - 2024-03-28 | Strong Buy |
Compugen LtdCGEN | +150.49% | $1.03 | $2.58 | 2023-08-07 - 2024-03-28 | Strong Buy |
Merus NvMRUS | +149.13% | $19.46 | $48.48 | 2023-03-01 - 2024-02-29 | Strong Buy |
Compugen LtdCGEN | +143.40% | $1.06 | $2.58 | 2023-05-26 - 2024-03-28 | Strong Buy |
Fate Therapeutics IncFATE | +115.88% | $3.40 | $7.34 | 2023-08-09 - 2024-03-28 | Strong Buy |
Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
---|---|---|---|---|---|---|
Century Therapeutics IncIPSC | 5 | Strong Buy | $16.00 | +282.78% | Reiterates | 8 months ago |
Adaptimmune Therapeutics PLCADAP | 8 | Strong Buy | $10.00 | +532.91% | Reiterates | 8 months ago |
Fate Therapeutics IncFATE | 4 | Strong Buy | $10.00 | +36.24% | Reiterates | 8 months ago |
Crispr Therapeutics AgCRSP | 7 | Strong Buy | $75.00 | +10.04% | Reiterates | 8 months ago |
Merus NvMRUS | 7 | Strong Buy | $35.00 | -22.27% | Reiterates | 8 months ago |
Gt Biopharma IncGTBP | 5 | Hold | $60.00 | +1,254.40% | Reiterates | 8 months ago |
Compugen LtdCGEN | 6 | Strong Buy | $13.00 | +403.88% | Reiterates | 8 months ago |
Bicycle Therapeutics PLCBCYC | 5 | Strong Buy | $50.00 | +100.80% | Reiterates | 8 months ago |
Allogene Therapeutics IncALLO | 7 | Strong Buy | $15.00 | +235.57% | Reiterates | 8 months ago |
G1 Therapeutics IncGTHX | 4 | Strong Buy | $19.00 | +339.81% | Reiterates | 8 months ago |
Bioatla IncBCAB | 6 | Strong Buy | $25.00 | +626.74% | Reiterates | 8 months ago |
Biomea Fusion IncBMEA | 3 | Strong Buy | $43.00 | +187.63% | Reiterates | 8 months ago |
Pyxis Oncology IncPYXS | 1 | Strong Buy | $15.00 | +252.11% | Initiates Coverage On | 8 months ago |
Viracta Therapeutics IncVIRX | 1 | Strong Buy | $10.00 | +880.39% | Initiates Coverage On | 8 months ago |
Cel Sci CorpCVM | 3 | Strong Buy | $10.00 | +423.56% | Reiterates | 9 months ago |
Calcimedica IncCALC | 2 | Strong Buy | $17.00 | +308.65% | Reiterates | 9 months ago |
Agenus IncAGEN | 4 | Strong Buy | $8.30 | +1,331.03% | Reiterates | 9 months ago |
Replimune Group IncREPL | 4 | Strong Buy | $60.00 | +634.39% | Reiterates | 10 months ago |
In8bio IncINAB | 4 | Strong Buy | $8.00 | +577.97% | Reiterates | 10 months ago |
Aravive IncARAV | 5 | Strong Buy | $10.00 | +24,900.00% | Reiterates | 10 months ago |
Volitionrx LtdVNRX | 1 | Strong Buy | $6.00 | +692.60% | Assumes | 10 months ago |
Hcw Biologics IncHCWB | 1 | Strong Buy | $9.00 | +414.29% | Assumes | 10 months ago |
Rain Oncology IncRAIN | 6 | Hold | $2.00 | +65.29% | Maintains | 10 months ago |
Apexigen IncAPGN | 4 | Hold | $0.64 | +66.23% | Reiterates | 10 months ago |
Ocean Biomedical IncOCEA | 1 | Strong Buy | $17.00 | +349.14% | Assumes | 10 months ago |
Atreca IncBCEL | 2 | Strong Buy | $10.00 | +6,566.67% | Reiterates | a year ago |
Tcr2 Therapeutics IncTCRR | 3 | Hold | $2.00 | N/A | Reiterates | a year ago |
Atara Biotherapeutics IncATRA | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | a year ago |
Genenta Science SpaGNTA | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | a year ago |
Ayala Pharmaceuticals IncAYLA | 2 | Strong Sell | $0.55 | N/A | Downgrades | a year ago |
Humanigen IncHGENQ | 2 | Hold | $2.00 | N/A | Downgrades | 2 years ago |
Marker Therapeutics IncMRKR | 2 | Hold | $10.00 | N/A | Downgrades | 2 years ago |
Compass Therapeutics IncCMPX | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 2 years ago |
Translate Bio IncTBIO1 | 3 | Hold | $38.00 | N/A | Maintains | 3 years ago |
Intellia Therapeutics IncNTLA | 2 | Strong Buy | $110.00 | N/A | Maintains | 3 years ago |
Panbela Therapeutics IncPBLA | 1 | Strong Buy | $240,000.00 | N/A | Initiates Coverage On | 3 years ago |
Nextcure IncNXTC | 1 | Strong Buy | $80.00 | N/A | Initiates Coverage On | 4 years ago |
Arqule IncARQL | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |